Publication | Closed Access

MK-801 prevents brain lesions and delayed-nonmatching-to-sample deficits produced by pyrithiamine-induced encephalopathy in rats.

Neurodegenerative DiseasesNeurobiology Of DiseaseMedicineExperimental NeuropathologyPharmacologyDelayed-nonmatching-to-sample DeficitsNeuropharmacologyNeuroprotectionNeurologyNeuroscienceBrain InjuryMolecular NeurobiologyNeuroimmunologyNeurochemistrySocial SciencesPyrithiamine-induced Encephalopathy